7,750 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Purchased by Zweig DiMenna Associates LLC

Zweig DiMenna Associates LLC bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, Holdings Channel reports. The firm bought 7,750 shares of the biotechnology company’s stock, valued at approximately $4,606,000.

Other hedge funds have also recently modified their holdings of the company. Groupama Asset Managment bought a new position in Axon Enterprise in the 3rd quarter valued at $200,000. Massachusetts Financial Services Co. MA bought a new position in shares of Axon Enterprise in the third quarter worth about $120,553,000. International Assets Investment Management LLC purchased a new position in Axon Enterprise in the 3rd quarter worth about $871,860,000. Westfield Capital Management Co. LP lifted its holdings in Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after buying an additional 127,769 shares in the last quarter. Finally, Assenagon Asset Management S.A. boosted its position in Axon Enterprise by 328.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after buying an additional 111,405 shares during the period. Institutional investors own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Julie A. Cullivan sold 1,261 shares of Axon Enterprise stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the transaction, the director now owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 50,545 shares of company stock worth $30,721,337 over the last three months. 6.10% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

AXON has been the topic of a number of research reports. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. TD Cowen assumed coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. The Goldman Sachs Group upped their target price on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. JMP Securities raised their price target on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. Finally, Robert W. Baird upped their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $504.92.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $611.43 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The business has a fifty day moving average of $617.43 and a 200 day moving average of $467.42. The firm has a market capitalization of $46.62 billion, a price-to-earnings ratio of 157.99, a price-to-earnings-growth ratio of 6.09 and a beta of 1.04. Axon Enterprise, Inc. has a 1 year low of $247.04 and a 1 year high of $698.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.